Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 2, 2004 - Issue 4
Submit an article Journal homepage
57
Views
6
CrossRef citations to date
0
Altmetric
Review

Tuberculosis in pregnancy: current recommendations for screening and treatment in the USA

Kimberly G Bergeron Obstetrics and Gynecology Residency Program, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA. [email protected]
,
Robert G Bonebrake Department of Obstetrics and Gynecology, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA. [email protected]
&
Caron J Gray Department of Obstetrics and Gynecology, One World Community Health Center (formerly Indian Chicano Health Center), Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA. [email protected]
Pages 589-598 | Published online: 10 Jan 2014

References

  • Diwan VK, Thorson A. Sex, gender and tuberculosis. Lancet 353,1000–1001 (1999).
  • Holmes CB, Hausler H, Nunn P. A review of the sex differences in the epidemiology of tuberculosis. Int. J. Tuberc. Lung Dis. 2, 96–99 (1998).
  • Centers for Disease Control and Prevention. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment: recommendations of the Advisory Council for the Elimination of Tuberculosis. Morb. Mortal. Wkly Rep. 48(RR-9) 1–13 (1999).
  • Zuber PLF, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. J. Am. Med. Assoc. 278, 304–307 (1997).
  • Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1994. J. Am. Med. Assoc. 272, 535–539 (1994).
  • Centers for Disease Control and Prevention. Treatment of tuberculosis. Morb. Mortal. Wkly Rep. 52,1–77 (2003).
  • • Explains the current recommendations of the US Centers for Disease Control and Prevention (CDC) for the screening and treatment of latent tuberculosis. It also contains recommendations for screening and treatment of latent tuberculosis in pregnancy, and reviews recent research into alternative drug regimens for latent tuberculosis treatment.
  • McKenna MT, McCray E, Jones JL, Onorato IM, Castro KG. The fall after the rise: tuberculosis in the United States, 1991 through 1994. Am. J. Public Health 88, 1059–1063 (1994).
  • American Thoracic Society, Centers for Disease Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161, S221—S247 (2000).
  • •Describes current recommendations of theCDC for the treatment of active tuberculosis and also covers adverse effects of common antituberculosis medications.
  • Centers for Disease Control and Prevention. Reported Tuberculosis in the United States. US Department of Health and Human Services, CDC (2002).
  • American Thoracic Society. Preventive treatment in tuberculosis. Am. Rev. Respir. Dis. 91,297–298 (1965).
  • American Thoracic Society. Chemoprophylaxis for the prevention of tuberculosis. Am. Rev. Respir. Dis. 96, 558–562 (1967).
  • Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis. Am. Rev. Respir. Dis. 117,991–1001 (1978).
  • Franks AL, Binkin NJ, Snider DE, Rokaw WM, Becker S. Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Pub. Health Rep. 104,151–155 (1989).
  • •A study of isoniazid hepatitis in pregnantpatients that helped to shape current practices of postpartum treatment of latent tuberculosis infection (LTBI).
  • Gordin F, Chaisson RE, Matts JP, et al Rifampin and pyrazinamide versus isoniazid for prevention of tuberculosis in HIV-infected persons: an international, randomized trail. J. Am. Med. Assoc. 283(11) 1445–1450 (2000).
  • Hong Kong Chest Service, Tuberculosis Research Center, Madra and British Medical Research Council. A double-blind, controlled clinic trial of three antituberculosis regimens in patients with silicosis in Hong Kong. Am. Rev. Respir. Dis. 145,36–41 (1992).
  • Bothamley G. Drug treatment of tuberculosis during pregnancy, safety considerations. Drug Saf 24,553–565 (2001).
  • Snider DE Jr, Layde PM, Johnson MW, Lyle MA. Treatment of tuberculosis during pregnancy. Am. Rev. Respir. Dis. 122,65–69 (1980).
  • Centers for Disease Control and Prevention. Public health dispatch update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection. Morb. Mortal Wkly Rep. 51,998–999 (2002).
  • •A complete report by the CDC of recommendations for the screening and treatment of LTBI. It reviews the history of isoniazid use in the USA. It also reviews recent research of alternative therapy for latent tuberculosis.
  • Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am. Rev. Respir. Dis. 85, 490–521 (1962).
  • Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Morb. Mortal Wkly Rep. 49,1–53 (2000).
  • Miller KS, Miller JM. Tuberculosis in pregnancy: interactions, diagnosis, and management. Clin. Obstet. Gynecol 39, 120–142 (1996).
  • Robinson CA, Rose NC. Tuberculosis: current implications and management in obstetrics. Obstet. Gynecol Survey 51, 115–124 (1996).
  • Medchill MT, Gillum M. Diagnosis and management of tuberculosis during pregnancy. Obstet. Gynecol Survey 44, 81–84 (1989).
  • Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multiple drug resistance: recommendations of the advisory committee on the elimination of tuberculosis. Morb. Mortal. Wkly Rep. 42, 1–22 (1993).
  • Cohn DL. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control. Clin. Infect. Dis. 31, 120–124 (2000).
  • •Reviews the CDC recommendations for treatment of latent tuberculosis. It concisely explains the new nomenclature the CDC has adopted and emphasizes the importance of treatment of latent tuberculosis as a part of a tuberculosis elimination strategy.
  • Snider DE, Powell KE. Should women taking antituberculosis drugs breast feed? Arch. Intern. Med. 144,589–591 (1984).
  • Shin S, Guerra D, Rich M, et al. Treatment of multidrug resistant tuberculosis during pregnancy: a report of seven cases. Clin. Infect. Dis. 36,996–1003 (2003)
  • Nitta AT, Milligan D. Management of four pregnant women with multidrug resistant tuberculosis. Clin. Infect. Dis. 28, 1298–1304 (1999).
  • Lessnau KD, Qarah S. Multidrug resistant tuberculosis in pregnancy: case report and review of the literature. Chest 123,953–956 (2003).
  • Good JT Jr, Isemen MD, Davidson PT, Lakshnminarayan S, Sohn SA. Tuberculosis in association with pregnancy. Am. J. Obstet. Gynecol 113,602–606 (1981).
  • Millard PS, Wilcosky TC, Reade-Christopher SJ, Weber DJ. Isoniazid-related fatal hepatitis. West. J. Med. 164, 486–491 (1996).
  • Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy. J. Am. Med. Assoc. 281, 1014–1018 (1999).
  • Salpeter SR, Sanders GD, Salpeter EE, Owens DK. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis. Ann. Intern. Med. 127,1051–1061 (1997).
  • •This study followed patients on isoniazid therapy with clinical monitoring and found a much lower rate of isoniazid hepatitis.
  • Boggess KA, Myers ER, Hamilton CD. Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet. Gynecol 96,757–762 (2000).
  • • Compares antepartum and postpartum treatment of latent tuberculosis. It uses a Markov decision-analysis model. This study showed that antepartum treatment resulted in decreased morbidity and mortality and was the most cost-effective strategy.
  • Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. Morb. Mortal. Wkly Rep. 44(RR-11), 1–16 (1995).
  • American Thoracic Society, Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149,1359–1374 (1994).
  • Bergeron KG, Bonebrake RG, Allen C, Gray CJ. Latent tuberculosis in pregnancy: screening and treatment. Curr. Womens Health Rep. 3,303–308 (2003).
  • Medch ill MT Prenatal purified protein derivative skin testing in a teaching clinic with a large Hispanic population. Am. J. Obstet. Gynecol. 180,1579–1583 (1999).
  • Perkins MD. New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis. 4(12), S182—S188 (2000).

Websites

  • Centers for Disease Control and Prevention. Reported TB cases, United States, 1981–2001 (2001). www.cdc.gov/nchstp/tb/ (Accessed July 2004)
  • •Compilation of tuberculosis statistics in the USA in 2001, containing graphs of trends in case rates over the last decade.
  • Centers for Disease Control and Prevention. The use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis (1990). aepo-xdv-www.epo.cdc.gov/wonder/ prevguid/m001643/m0001643.html (Accessed July 2004)
  • WHO Fact Sheet No. 104, revised March 2004. www.who.indentity/en (Accessed July 2004)
  • Centers for Disease Control and Prevention. TB Care Guide (1998). www.ci.nc.ny.ushtml/doh/html/tb/cpp3.html (Accessed July 2004)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.